UNLOCK the €10 trillion healthcare revolution
As the world’s leading healthtech venture builder, NLC Health Ventures has pioneered a transformative approach to healthcare innovation, offering institutional investors an opportunity to access a diversified portfolio of high-impact ventures.
NLC’s venture-building model de-risks early-stage investments through a combination of expertise and scale. With a team of over 80 healthcare professionals, scientists, and investment experts, we possess the deep industry knowledge needed to build and scale the most promising innovations.
The NLC Health Impact Fund, fully compliant with SFDR9 standards, is positioned to unlock the potential of the €10 trillion market.
get in touch
Book a call with our investment team to discover how you can position yourself at the forefront of the €10 trillion healthcare revolution. In a short call, we will provide an introduction to our fund, explain the investment process, and answer any questions you might have.
From our investors
We invest in innovative companies that keep healthcare accessible and affordable. We see major challenges in healthcare, for which NLC can find suitable innovations from around the world and build them into companies. Our collaboration will make it possible to get these innovations to the patient faster.
VGZ
Dutch Health Insurer
I love businesses that find the sweet spot of combining a successful business model disruption with having a positive impact. These companies are the winners of the future. NLC is clearly in that category of combining great societal benefits with a great financial return.
Remco van Zanten
Investor and former board member of Booking.com
High quality VC funds in the health space are relatively rare in Europe, especially when combined with the expertise, depth and strength of the team. Moreover the quality of their process, combined with the truly building companies as a venture builder and then providing access to the portfolio companies gives them an undeniable edge when it comes to both impact and return expectations.
Avalon Hill Management
Family Office
I invested in NLC because it has built a disruptive platform for investment in the (pre)seed phase, generating both high societal impact and high return. For me it is an exciting novel asset category, I am pleased to be part of this journey.
Ivo Lurvink
Founder of True Value Partners and ex-partner at CVC Capital Partners
Insights
%2520980x600.jpeg)
.webp)
Create a healthier future with us
Nina Rijnders
Investor Relations